Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | FORM S-1 | inmune_s1.htm | S-1 | 1238198 |
| 2 | CERTIFICATE OF INCORPORATION | inmune_ex31.htm | EX-3.1 | 5374 |
| 3 | BYLAWS | inmune_ex32.htm | EX-3.2 | 46112 |
| 4 | SUBSCRIPTION AGREEMENT | inmune_ex101.htm | EX-10.1 | 92061 |
| 5 | LICENSE AGREEMENT | inmune_ex102.htm | EX-10.2 | 94115 |
| 6 | ASSIGNMENT AND ASSUMPTION AGREEMENT | inmune_ex103.htm | EX-10.3 | 6949 |
| 7 | EXCLUSIVE LICENSE AGREEMENT | inmune_ex104.htm | EX-10.4 | 96707 |
| 8 | FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT | inmune_ex105.htm | EX-10.5 | 10142 |
| 9 | JOINT DEVELOPMENT AGREEMENT | inmune_ex106.htm | EX-10.6 | 9722 |
| 10 | MATERIAL TRANSFER AGREEMENT AND LICENCE | inmune_ex107.htm | EX-10.7 | 66356 |
| 11 | EMPLOYMENT AGREEMENT | inmune_ex108.htm | EX-10.8 | 87892 |
| 12 | EMPLOYMENT AGREEMENT | inmune_ex109.htm | EX-10.9 | 87194 |
| 13 | MARK LOWDELL | inmune_ex1010.htm | EX-10.10 | 17278 |
| 14 | STOCK INCENTIVE PLAN | inmune_ex1011.htm | EX-10.11 | 101181 |
| 15 | INCENTIVE OPTION AGREEMENT WITH EMPLOYEES | inmune_ex1012.htm | EX-10.12 | 33466 |
| 16 | INCENTIVE OPTION AGREEMENT WITH NON-EMPLOYEE DIRECTORS | inmune_ex1013.htm | EX-10.13 | 27828 |
| 17 | CONSULTING AGREEMENT | inmune_ex1014.htm | EX-10.14 | 41630 |
| 18 | EX-10.15 | inmune_ex1015.htm | EX-10.15 | 108544 |
| 19 | EX-10.16 | inmune_ex1016.htm | EX-10.16 | 135851 |
| 20 | EX-10.17 | inmune_ex1017.htm | EX-10.17 | 10634 |
| 21 | EX-10.20 | inmune_ex1020.htm | EX-10.20 | 6788 |
| 22 | SUBSIDIARIES | inmune_ex211.htm | EX-21.1 | 1604 |
| 23 | CONSENT OF AUDITOR | inmune_ex232.htm | EX-23.2 | 1567 |
| 24 | inmune_ex106img1.jpg | GRAPHIC | 33928 | |
| 25 | inmune_ex31img19.jpg | GRAPHIC | 137626 | |
| 26 | inmune_ex31img20.jpg | GRAPHIC | 63586 | |
| 27 | inmune_ex31img21.jpg | GRAPHIC | 106566 | |
| 28 | inmune_ex31img22.jpg | GRAPHIC | 79940 | |
| 29 | inmune_ex31img23.jpg | GRAPHIC | 114053 | |
| 30 | inmune_ex31img24.jpg | GRAPHIC | 92560 | |
| 31 | inmune_ex31img25.jpg | GRAPHIC | 180025 | |
| 32 | inmune_ex31img26.jpg | GRAPHIC | 164794 | |
| 33 | inmune_ex31img27.jpg | GRAPHIC | 121386 | |
| 34 | inmune_ex107img3.jpg | GRAPHIC | 339824 | |
| 35 | inmune_ex1010img1.jpg | GRAPHIC | 11600 | |
| 36 | inmune_s1img1.jpg | GRAPHIC | 7274 | |
| 37 | inmune_s1img10.jpg | GRAPHIC | 66315 | |
| 38 | inmune_s1img11.jpg | GRAPHIC | 109402 | |
| 39 | inmune_s1img12.jpg | GRAPHIC | 60062 | |
| 40 | inmune_s1img13.jpg | GRAPHIC | 79628 | |
| 41 | inmune_s1img14.jpg | GRAPHIC | 72240 | |
| 42 | inmune_s1img9.jpg | GRAPHIC | 56599 | |
| 43 | inmune_ex1010img10.jpg | GRAPHIC | 296511 | |
| 44 | inmune_ex1010img11.jpg | GRAPHIC | 321537 | |
| 45 | inmune_ex1010img12.jpg | GRAPHIC | 314853 | |
| 46 | inmune_ex1010img13.jpg | GRAPHIC | 392481 | |
| 47 | inmune_ex1010img14.jpg | GRAPHIC | 241139 | |
| 48 | inmune_ex1010img15.jpg | GRAPHIC | 343400 | |
| 49 | inmune_ex1010img16.jpg | GRAPHIC | 222028 | |
| 50 | inmune_ex1010img17.jpg | GRAPHIC | 79668 | |
| 51 | inmune_ex1010img2.jpg | GRAPHIC | 278120 | |
| 52 | inmune_ex1010img3.jpg | GRAPHIC | 297337 | |
| 53 | inmune_ex1010img4.jpg | GRAPHIC | 346738 | |
| 54 | inmune_ex1010img5.jpg | GRAPHIC | 300775 | |
| 55 | inmune_ex1010img6.jpg | GRAPHIC | 330953 | |
| 56 | inmune_ex1010img7.jpg | GRAPHIC | 382685 | |
| 57 | inmune_ex1010img8.jpg | GRAPHIC | 286079 | |
| 58 | inmune_ex1010img9.jpg | GRAPHIC | 342829 | |
| 59 | inmune_ex106img19.jpg | GRAPHIC | 270468 | |
| Complete submission text file | 0001640334-18-001703.txt | 11896220 |
IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-227122 | Film No.: 181047844
SIC: 2836 Biological Products, (No Diagnostic Substances)
